Analgesics in Brazil

Date: September 23, 2016
Pages: 31
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ADCDC87C54EEN
Leaflet:

Download PDF Leaflet

Analgesics was the most important category in consumer health in Brazil in 2016, accounting for 36% of overall OTC value sales. During the same year, the category posted current value growth of 9% to reach sales of B$6.0 billion, although this was a slower performance than the review period current value CAGR of 11%. This slowdown can be mainly attributed to the economic recession in Brazil, which is having a significant negative impact on consumer confidence.

Euromonitor International's Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 1 Bayer (Brasil) SA: Key Facts
Competitive Positioning
  Summary 2 Bayer (Brasil) SA: Competitive Position 2016
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 3 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Competitive Positioning
  Summary 4 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2016
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 5 EMS SA: Key Facts
Competitive Positioning
  Summary 6 EMS SA: Competitive Position 2016
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 7 Hypermarcas SA: Key Facts
  Summary 8 Hypermarcas SA: Operational Indicators
Competitive Positioning
  Summary 9 Hypermarcas SA: Competitive Position 2016
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 10 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Competitive Positioning
  Summary 11 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2016
Executive Summary
Economic Slowdown Persists, Affecting Non-priority Categories More Intensely
Increasing Acceptance of Self-medication/self-care Due To Broadened Accessibility
Aggressive Pricing of Private Label Products Threatens the Competitiveness of Manufacturers
Sports Nutrition Manufacturers Expand Their Portfolios and Invest in Segmentation
Consumer Health Is Expected To Grow at A Slower Pace Over the Forecast Period
Key Trends and Developments
OTC Performs Relative Well During the Economic Slowdown As Growth Rates Slow
Health and Wellness Trend Dips As Prioritisation of Spending Negative Influences Sales of Vitamins and Dietary Supplements
Affordability Gains More Importance in the Strategies of Manufacturers
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
  Summary 12 Research Sources












Skip to top


OTC Pharmaceuticals in Brazil US$ 350.00 Sep, 2016 · 38 pages

Ask Your Question

Analgesics in Brazil
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: